Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: Canada Clear all

121 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20021
20053
20076
20085
20099
20106
20114
20123
20135
20143
20156
20167
20174
20189
20198
20205
20216
20224
20238
20244
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed63
Recruiting19
Active, not recruiting14
Terminated12
Unknown status7
Withdrawn4
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto18
Bayer9
Bristol-Myers Squibb8
AstraZeneca5
British Columbia Cancer Agency3
Hoffmann-La Roche3
Merck Sharp & Dohme LLC3
NCIC Clinical Trials Group3
National Cancer Institute (NCI)3
Pfizer3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular121
Liver Neoplasms34
Neoplasms16
Carcinoma, Non-Small-Cell Lung9
Stomach Neoplasms7
Carcinoma, Renal Cell6
Cholangiocarcinoma6
Ovarian Neoplasms6
Squamous Cell Carcinoma of Head and Neck6
Carcinoma5

Trials

Showing 76 to 100 of 121. Each trial links to its page on Pharma Observatory.

21 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.